[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368809-105":59,"doc-detail-368809-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","role-of-toll-like-receptors-in-myeloid-neoplasms-focuses-on-the-molecular-mechanisms-and-clinical-impact-on-myelodysplastic-syndromes-acute-myeloid-leukemia-and-chronic-myeloid-leukemia","Role of Toll-Like Receptors in Myeloid Neoplasms - Focuses on the Molecular Mechanisms and Clinical Impact on Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myeloid Leukemia","","Toll-like receptors (TLRs) are innate immune pattern recognition receptors that detect pathogen- and damage-associated molecular patterns (PAMPs and DAMPs). In myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML), TLRs regulate inflammation, disease progression, and treatment response through pathways involving MyD88, and they can both enhance antitumor immunity and drive leukemogenesis. TLR dysregulation in MDS and AML links to poor prognosis and genomic instability, while in CML TLR signaling supports a protective microenvironment via NOD-like and TNF-α routes. The review also evaluates TLR-targeting agonists and antagonists and discusses how genetic variation may shape infection susceptibility and personalized therapeutic strategies, including combination approaches such as purine nucleoside phosphorylase inhibitors.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-toll-like-receptors-in-myeloid-neoplasms-focuses-on-the-molecular-mechanisms-and-clinical-impact-on-myelodysplastic-syndromes-acute-myeloid-leukemia-and-chronic-myeloid-leukemia/368809/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-toll-like-receptors-in-myeloid-neoplasms-focuses-on-the-molecular-mechanisms-and-clinical-impact-on-myelodysplastic-syndromes-acute-myeloid-leukemia-and-chronic-myeloid-leukemia/368809.png","ImageObject",300,407,{"name":92,"@type":93},"Aran","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What roles do Toll-like receptors play in myeloid neoplasms?","Question",{"text":113,"@type":114},"TLRs act as pattern recognition receptors that detect PAMPs and DAMPs, influencing inflammation, disease progression, and therapeutic responses in MDS, AML, and CML.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does TLR signaling relate to prognosis and genomic instability?",{"text":118,"@type":114},"TLR dysregulation in MDS and AML is associated with poor prognosis and genomic instability, reflecting disrupted immune regulation and disease biology.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic approaches targeting TLRs are discussed?",{"text":122,"@type":114},"The review highlights TLR agonists and antagonists as promising strategies to enhance antitumor responses, including potential combination regimens such as purine nucleoside phosphorylase inhibitors.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368809,1790207134,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Journal of Pathology, Microbiology and Immunology  \nRole of Toll-Like Receptors in Myeloid Neoplasms: Focuses on the Molecular Mechanisms and Clinical Impact on Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myeloid Leukemia  \nClarissa Brenda Alves Cavalcante1 | Alessandro Cavalcante Chaves1 | Vanessa Silva de Oliveira1 | Maria Amanda Silva de Araújo1 | Thayres Marinho Cunha e Silva1 | João Vitor Caetano Goes1,2 | Roberta Taiane Germano de Oliveira1 | Ronald Feitosa Pinheiro1,3,4 | Howard Lopes Ribeiro-Junior1,2,4   \n1Cancer Cytogenomic Laboratory, Center for Research and Drug Development (NPDM), Federal University of Ceara, Fortaleza, Ceara, Brazil | 2Post  \nGraduate Program of Pathology, Federal University of Ceara, Fortaleza, Ceara, Brazil | 3Post-Graduate Program in Medical Science, Federal University of Ceara, Fortaleza, Ceara, Brazil | 4Post-Graduate Program of Translational Medicine, Federal University of Ceara, Fortaleza, Ceara, Brazil Correspondence: Howard Lopes Ribeiro-Junior ([howard@ufc.br](howard@ufc.br))  \nReceived: 16 May 2025 | Revised: 12 August 2025 | Accepted: 21 August 2025  \nFunding: This research was funded by the Brazilian Ministry of Science and Technology supported by the National Council for Scientific and Technological Development (CNPq) entitled: “UNIVERSAL CNPq/MCTI/FNDCT No. 18/2021—Faixa B—Grupos Consolidados—\\#422726/2021-4—Análise da via STING de pacientes com Síndrome Mielodisplásica primária e de modelos de lesão de fita dupla de DNA secundária a quimioterápicos empacientes oncológicos e camundongos C57BL/6.” This research was funded by the Brazilian Ministry of Science and Technology supported by National Council for Scientific and Technological Development (CNPq) entitled: “CHAMADA CNPQ/MCTI/CT-BIOTEC No 30/2022—Linha 2: Novas tecnologiasem Biotecnologia—\\#440389/2022-4—Desenvolvimento de linhagens geneticamente modificadas por crispr/cas9 com perda de função do gene TP53: induzindo o fenótipo de instabilidade genômica da Neoplasia Mielodisplásica (SMD).” This research was funded by the Instituto Nacional de Ciência e Tecnologiado Sangue (INCT do Sangue/\\#405918/2022-4). Howard Lopes Ribeiro-Junior is recipient of a CNPq Research Productivity Scholarship—Level 2 (Project: Chamada CNPq No. 09/2023—Bolsas de Produtividade em Pesquisa—PQ \\#305659/2023-5). This research was funded by the Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico (FUNCAP) (UNI-0210-00007.01.00/23) entitled: “Estabelecimento de um Escore de Risco Poligênico (PRS) para a Neoplasia Mielodisplásica no idoso: uma coorte Brasileira”.  \nKeywords: biomarkers | innate immune system | myeloid neoplasms | toll-like receptors  \nABSTRACT  \nToll-like receptors (TLRs) are essential components of the innate immune system, functioning as pattern recognition receptors (PRRs) to detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) . In hematological malignancies, particularly myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML), TLRs influence inflammation, disease progression, and therapeutic response. This review highlights the prognostic relevance of TLR expression, the role of the MyD88 signaling pathway in clonal evolution, and the dual nature ofTLR-mediated immune responses, either promoting antitumor activity or contributing to leukemogenesis. Notably, TLR dysregulation in MDS and AML is associated with poor prognosis and genomic instability, whereas in CML, TLRs contribute toa protective microenvironment via NOD-like and TNF-α pathways. Therapeutic strategies targeting TLRs, including agonistsand antagonists, show promise in enhancing antitumor responses, especially when combined with agents like purine nucleoside phosphorylase inhibitors. Furthermore, genetic variations in TLR pathways may influence individual susceptibility to infection  \n\n| Clarissa Brenda Alves Cavalcante and Alessandro Cavalcante","cbCailO7bvbNFIlP","https://ap.wps.com/l/cbCailO7bvbNFIlP","pdf",681205,18,"English","# Introduction\n## Innate immunity and pattern recognition receptors (PRRs)\n## Toll-like receptors (TLRs) in myeloid neoplasms","[{\"question\":\"What roles do Toll-like receptors play in myeloid neoplasms?\",\"answer\":\"TLRs act as pattern recognition receptors that detect PAMPs and DAMPs, influencing inflammation, disease progression, and therapeutic responses in MDS, AML, and CML.\"},{\"question\":\"How does TLR signaling relate to prognosis and genomic instability?\",\"answer\":\"TLR dysregulation in MDS and AML is associated with poor prognosis and genomic instability, reflecting disrupted immune regulation and disease biology.\"},{\"question\":\"What therapeutic approaches targeting TLRs are discussed?\",\"answer\":\"The review highlights TLR agonists and antagonists as promising strategies to enhance antitumor responses, including potential combination regimens such as purine nucleoside phosphorylase inhibitors.\"}]","Role of Toll-Like Receptors in Myeloid Neoplasms - Focuses on the Molecular Mechanisms and Clinical Impact on Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myeloid Leukemia | PDF",1790178710,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/760445918df6679f9b2c82ea6740741f.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5352e26716c6f7aa5329c90a9ddd8eb6.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59195d1fda4e6836bab1633fa9249b3e.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d943a873b2695ee0e9c8687d27a91d81.webp",980,1287]